Qiming Venture Partners’ deep pockets just got even deeper.
Almost two years after closing its seventh fund, the storied Chinese VC firm has hit $2.5 billion for Fund VIII, with a main fund covering both technology and consumer and healthcare investments, as well as a parallel fund specializing in healthcare.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,